ID   LUCC4
AC   CVCL_W895
DR   Cosmic; 1286011
DR   Cosmic; 2050452
DR   Cosmic; 2686104
DR   Wikidata; Q54903250
RX   PubMed=19802009;
RX   PubMed=24035680;
RX   PubMed=24367658;
RX   PubMed=29732388;
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=24035680).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 19-12-24; Version: 10
//
RX   PubMed=19802009; DOI=10.1038/onc.2009.315;
RA   Askham J.M., Platt F.M., Chambers P.A., Snowden H., Taylor C.F.,
RA   Knowles M.A.;
RT   "AKT1 mutations in bladder cancer: identification of a novel oncogenic
RT   mutation that can co-operate with E17K.";
RL   Oncogene 29:150-155(2010).
//
RX   PubMed=24035680; DOI=10.1016/j.eururo.2013.08.057;
RA   Hurst C.D., Platt F.M., Knowles M.A.;
RT   "Comprehensive mutation analysis of the TERT promoter in bladder
RT   cancer and detection of mutations in voided urine.";
RL   Eur. Urol. 65:367-369(2014).
//
RX   PubMed=24367658; DOI=10.1371/journal.pone.0084411; PMCID=PMC3867501;
RA   Ross R.L., Burns J.E., Taylor C.F., Mellor P., Anderson D.H.,
RA   Knowles M.A.;
RT   "Identification of mutations in distinct regions of p85 alpha in
RT   urothelial cancer.";
RL   PLoS ONE 8:E84411-E84411(2013).
//
RX   PubMed=29732388; DOI=10.3233/BLC-180167; PMCID=PMC5929350;
RA   Zuiverloon T.C.M., de Jong F.C., Costello J.C., Theodorescu D.;
RT   "Systematic review: characteristics and preclinical uses of bladder
RT   cancer cell lines.";
RL   Bladder Cancer 4:169-183(2018).
//